A
Ann G. Zauber
Researcher at Memorial Sloan Kettering Cancer Center
Publications - 266
Citations - 26609
Ann G. Zauber is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Colorectal cancer & Colonoscopy. The author has an hindex of 67, co-authored 244 publications receiving 23619 citations.
Papers
More filters
Journal ArticleDOI
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
Ann G. Zauber,Sidney J. Winawer,Michael J. O'Brien,Iris Lansdorp-Vogelaar,Marjolein van Ballegooijen,Benjamin F. Hankey,Weiji Shi,John H. Bond,Melvin Schapiro,Joel F. Panish,Stewart Et,Jerome D. Waye +11 more
TL;DR: Findings support the hypothesis that colonoscopic removal of adenomatous polyps prevents death from colorectal cancer.
Journal ArticleDOI
Cardiovascular Risk Associated With Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
Scott D. Solomon,John J.V. McMurray,Marc A. Pfeffer,Janet Wittes,Robert A. Fowler,Peter V. Finn,William F. Anderson,Ann G. Zauber,Ernest T. Hawk,Monica M. Bertagnolli +9 more
TL;DR: Celecoxib use was associated with a dose-related increase in the composite end point of death from cardiovascular causes, myocardial infarction, stroke, or heart failure, providing further evidence that the use of COX-2 inhibitors may increase the risk of serious cardiovascular events.
Journal ArticleDOI
Annual Report to the Nation on the Status of Cancer, 1975-2006, Featuring Colorectal Cancer Trends and Impact of Interventions (Risk Factors, Screening, and Treatment) to Reduce Future Rates
Brenda K. Edwards,Elizabeth Ward,Betsy A. Kohler,Christie R. Eheman,Ann G. Zauber,Robert N. Anderson,Ahmedin Jemal,Maria J. Schymura,Iris Lansdorp-Vogelaar,Laura C. Seeff,Marjolein van Ballegooijen,S. Luuk Goede,Lynn A. G. Ries +12 more
TL;DR: This year's report includes trends in colorectal cancer incidence and death rates and highlights the use of microsimulation modeling as a tool for interpreting past trends and projecting future trends to assist in cancer control planning and policy decisions.
Journal ArticleDOI
Adenoma Detection Rate and Risk of Colorectal Cancer and Death
Douglas A. Corley,Christopher D. Jensen,Amy R. Marks,Wei K. Zhao,Jeffrey Lee,Chyke A. Doubeni,Ann G. Zauber,Jolanda de Boer,Bruce Fireman,Joanne E. Schottinger,Virginia P. Quinn,Nirupa R. Ghai,Theodore R. Levin,Charles P. Quesenberry +13 more
TL;DR: The adenoma detection rate was inversely associated with the risks of interval colorectal cancer, advanced-stage interval cancer, and fatal interval cancer.
Journal ArticleDOI
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
Monica M. Bertagnolli,Craig J. Eagle,Ann G. Zauber,Mark Redston,Scott D. Solomon,Kyung Mann Kim,Jie Tang,Rebecca B. Rosenstein,Janet Wittes,Donald K. Corle,Timothy Hess,G. Mabel Woloj,Frédéric Boisserie,William F. Anderson,Jaye L. Viner,Donya Bagheri,John Burn,Daniel C. Chung,Thomas Dewar,T. Raymond Foley,Neville E. Hoffman,Finlay A. Macrae,Ronald E. Pruitt,John R. Saltzman,Bruce Salzberg,Thomas Sylwestrowicz,Gary Gordon,Ernest T. Hawk +27 more
TL;DR: It is indicated that celecoxib is an effective agent for the prevention of colorectal adenomas but, because of potential cardiovascular events, cannot be routinely recommended for this indication.